X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES IPCA LABS JUBILANT LIFE SCIENCES/
IPCA LABS
 
P/E (TTM) x 20.1 27.7 72.6% View Chart
P/BV x 4.3 2.1 201.4% View Chart
Dividend Yield % 0.4 0.2 175.8%  

Financials

 JUBILANT LIFE SCIENCES   IPCA LABS
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
IPCA LABS
Mar-17
JUBILANT LIFE SCIENCES/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs187643 29.1%   
Low Rs65503 12.9%   
Sales per share (Unadj.) Rs364.3254.4 143.2%  
Earnings per share (Unadj.) Rs6.816.1 42.6%  
Cash flow per share (Unadj.) Rs24.529.8 82.3%  
Dividends per share (Unadj.) Rs3.001.00 300.0%  
Dividend yield (eoy) %2.40.2 1,364.6%  
Book value per share (Unadj.) Rs164.9194.6 84.8%  
Shares outstanding (eoy) m159.28126.20 126.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.32.3 15.4%   
Avg P/E ratio x18.435.7 51.6%  
P/CF ratio (eoy) x5.119.2 26.7%  
Price / Book Value ratio x0.82.9 25.9%  
Dividend payout %43.86.2 704.2%   
Avg Mkt Cap Rs m20,06172,300 27.7%   
No. of employees `0006.213.3 46.5%   
Total wages/salary Rs m11,0526,960 158.8%   
Avg. sales/employee Rs Th9,383.02,413.5 388.8%   
Avg. wages/employee Rs Th1,786.9523.2 341.5%   
Avg. net profit/employee Rs Th176.3152.4 115.6%   
INCOME DATA
Net Sales Rs m58,03432,106 180.8%  
Other income Rs m191226 84.4%   
Total revenues Rs m58,22432,332 180.1%   
Gross profit Rs m5,7864,448 130.1%  
Depreciation Rs m2,8121,730 162.6%   
Interest Rs m3,237241 1,344.4%   
Profit before tax Rs m-722,703 -2.7%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m696675 103.1%   
Profit after tax Rs m1,0902,028 53.8%  
Gross profit margin %10.013.9 72.0%  
Effective tax rate %-965.925.0 -3,867.0%   
Net profit margin %1.96.3 29.7%  
BALANCE SHEET DATA
Current assets Rs m29,28017,340 168.9%   
Current liabilities Rs m38,9129,559 407.1%   
Net working cap to sales %-16.624.2 -68.5%  
Current ratio x0.81.8 41.5%  
Inventory Days Days84100 84.1%  
Debtors Days Days5157 89.1%  
Net fixed assets Rs m55,71220,779 268.1%   
Share capital Rs m155252 61.2%   
"Free" reserves Rs m20,96824,499 85.6%   
Net worth Rs m26,26524,553 107.0%   
Long term debt Rs m17,1693,517 488.1%   
Total assets Rs m88,60639,595 223.8%  
Interest coverage x1.012.2 8.0%   
Debt to equity ratio x0.70.1 456.3%  
Sales to assets ratio x0.70.8 80.8%   
Return on assets %4.95.7 85.2%  
Return on equity %4.28.3 50.3%  
Return on capital %11.610.5 110.3%  
Exports to sales %37.848.6 77.7%   
Imports to sales %16.514.2 115.8%   
Exports (fob) Rs m21,93315,617 140.4%   
Imports (cif) Rs m9,5674,571 209.3%   
Fx inflow Rs m22,00415,617 140.9%   
Fx outflow Rs m11,7495,828 201.6%   
Net fx Rs m10,2559,790 104.8%   
CASH FLOW
From Operations Rs m8,0262,764 290.4%  
From Investments Rs m-1,744-1,432 121.8%  
From Financial Activity Rs m-4,447-1,591 279.5%  
Net Cashflow Rs m1,834-259 -708.8%  

Share Holding

Indian Promoters % 45.6 45.9 99.3%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 11.4 76.3%  
FIIs % 21.2 25.3 83.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 17.4 121.3%  
Shareholders   23,815 36,892 64.6%  
Pledged promoter(s) holding % 15.9 2.1 740.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   NATCO PHARMA  UNICHEM LAB  DR. REDDYS LAB  CADILA HEALTHCARE  ALEMBIC LTD  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Aug 18, 2017 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - NOVARTIS COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS